Table 3.

Correlation of CBX members mRNA expression level with OS and PFS in different clinical stages of ovarian cancer patients

CBX	Clinical stages	OS			PFS
		Cases	HR(95% CI)	P value	Cases	HR (95% CI)	P value
CBX1	I+II	135	4.65 (1.10 - 19.68)	0.0215*	163	1.69 (0.95 - 2.99)	0.0712
	III+IV	1220	1.39 (1.17 - 1.65)	0.0002*	1081	1.07 (0.92 - 1.25)	0.3714
CBX2	I+II	83	2.47 (0.88 - 6.89)	0.0753	115	1.77 (0.85 - 3.69)	0.1212
	III+IV	487	1.33 (1.01 - 1.76)	0.0399*	494	0.78 (0.63 - 0.96)	0.0213*
CBX3	I+II	135	1.81 (0.68 - 4.82)	0.2265	163	2.33 (1.30 - 4.17)	0.0035*
	III+IV	1220	1.25 (1.06 - 1.49)	0.0089*	1081	0.82 (0.70 - 0.95)	0.0101*

*P < 0.05.